Slide 1: FY22 AGM Presentation and Update
FY22 AGM Presentation and Update • World leading biotech • FY22 Results • Products, regulatory and IP • FY22 Achievements • FY23 Growth strategies Prof. Rob Phillips Chairman and CEO, Uscom Limited ASX: UCM Nov 10, 2022
Slide 2: Uscom Vision
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Vision “A great company, with great vision, technology and culture, and a great global opportunity” Our Team around the world Uscom has a mission to demonst
Slide 3: Uscom Medical Technology
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Medical Technology “Uscom is a world leading ASX listed, advanced medical technology company specialising in cardiovascular and pulmonary monitoring devices
Slide 4: Uscom Overview
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Overview ASX Listed Global Vision Global cardiovascular and Singapore HQ, China manufacture, pulmonary med tech Sydney, Budapest, UK, US. Visionary and inno
Slide 5: Uscom Snapshot
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Snapshot Uscom has an international footprint and is prepared for global growth in synch with global recovery 7 Global centres Expanding distribution hubs A
Slide 6: FY22 Results
FY21 Results Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook FY22 Results Sustained growth strategy with investment in the future UCM Total Receipts $4.7 million $3.26 million $3.48 million Cash on Hand Total R
Slide 7: Financial Results by Region
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Financial Results by Region Uscom Total Sales by Region – FY 2022 Asia Europe US/Other Australia 48% 36% 15% 1% of total sales of total sales of total sales of to
Slide 8: Products and Markets
FY21 Results Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Products and Markets High value technologies - large markets - strong predicted growth 3 high value product divisions – cardiac, hypertension/vascula
Slide 9: SpiroSonic AIR
FY21 Results Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook SpiroSonic AIR Next generation spirometry “Hospital in Home” – Asthma, COVID, COPD and Occupational Lung disease Applications - Research/CRO, hospita
Slide 10: VentiTest
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook VENTITEST The SpiroSonic VentiTest is a patent protected digital multi path ultrasonic ventilator testing and calibration solution which incorporates: Low resista
Slide 11: eHealth Growth Blue Sky
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook eHealth Growth Blue Sky Uscom eHealth Ecosystem • eHealth is a health delivery revolution • Uscom is committed to eHealth • BlueSky eHealth expected to underwrite
Slide 12: International Brands
FY21 Results Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook International Brands 5 great International Brands across 3 product divisions Blue Sky Uscom eHealth Ecosystem Reporter USCOM 1A SpiroReporter Uscom -
Slide 13: Global Approvals
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Global Approvals New Approvals for FY23 Regulatory Approvals China SE Asia Euro US Russia ROW New • London • • Budapest USCOM 1A Delaware • Beijing New New 2022 •
Slide 14: Publications – Clinical value
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Publications – Clinical value Uscom - leader in world cardiovascular and pulmonary science >600 Peer reviewed publications 56 Publications in FY22 25 In China in
Slide 15: Uscom Devices in World's Best Hospitals
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Devices in World’s Best Hospitals Europe – Slovenjia – Lubiana Asia - China - Europe - Poland – Chongqing University Medical Center Lodz PERIN Chongqing Asi
Slide 16: IP Value
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook IP Value Global Assets Next Generation Products Registered IP Uscom Ltd Uscom China Uscom Kft Total USCOM 1A 133 41 - 184 BP+ 23 - - 23 SpiroSonic 1 - 1 2 VentiTe
Slide 17: FY22 Achievements
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook FY22 Achievements Australia China Hungary Singapore UK US SE Asia Hub Singapore New IP and products Singapore regional HQ established Australia Operational bridge
Slide 18: FY22 Achievements
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook FY22 Achievements koneksa US Regulatory eHealth Products US FDA Application for SpiroSonic devices US Multiple products – hedges against competition US Food and D
Slide 19: FY22 Achievements
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook FY22 Achievements June Singapore Expansion Appointment of SE Asian BD and head of sales Singapore Emerging commercial centre of Asia Geopolitical neutrality and i
Slide 20: Foxconn Partnership
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Foxconn Partnership Worlds largest precision electronics manufacturer >40% of all global precision electronics • World’s largest precision electronic manufacturer
Slide 21: China Connection
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook China Connection “China is large, growing and with a special focus on advanced medical technology” China Recognition China National High Technology Enterprise (MO
Slide 22: Two Step Revenue Strategy
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Two Step Revenue Strategy Step 2 $30m Cardiac BP and Vascular Pulmonary Products: USCOM 1A Products: BP+ & BP+ Reporter Products: SpiroSonic FLO, Step 1 SMART, MO
Slide 23: FY23 Regional Growth Strategy
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook FY23 Regional Growth Strategy FY23 Australia Singapore China Hungary UK US Uscom SE Asia Singapore new operational focus linking SE Asia, China and Australia Regi
Slide 24: Uscom Value
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Uscom Value Advanced Global Medtech Company Impending value drivers Great company, with great vision, Foxconn partnership, 10 new products, US technology, culture
Slide 25: Summary
Uscom Ltd I FY2022 Annual General Meeting I uscom.com.au Chair's Update Uscom Overview FY22 Results Uscom Markets Milestones FY23 Outlook Summary “A great company, with great vision, technology and culture, and a great global opportunity” FY22 Continued growth and investment despite challenging busi
Slide 26: Corporate Responsibility
Corporate Responsibility One of the world’s great birds The Gouldian Finch (Erythrura Gouldiae) Benefiting from AWC care The wild populations in NW Australia used to number in the millions Now only ~2,500 mature individuals in total AWC are challenging extinction for the benefit of us all Uscom supp
Slide 27: Thank You
Thank You ASX: UCM Prof. Rob Phillips Chairman and CEO, Uscom Limited Nov 10, 2022